Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Leukemia, Myeloid, Acute 9Myelodysplastic Syndromes 7Brain Neoplasms 7Neoplasm Metastasis 6Recurrence 5Glioma 5Glioblastoma 5Lymphoma 4Leukemia, Lymphocytic, Chronic, B-Cell 4Head and Neck Neoplasms 4Sarcoma 3Neoplasms 3Leukemia 3Colorectal Neoplasms 3Breast Neoplasms 3Astrocytoma 3Uveal Melanoma 2Squamous Cell Carcinoma of Head and Neck 2Pancreatic Neoplasms 2Ovarian Neoplasms 2Neoplasms, Neuroepithelial 2Nasopharyngeal Carcinoma 2Mouth Neoplasms 2Melanoma 2Diffuse Intrinsic Pontine Glioma 2Urologic Neoplasms 1Urinary Bladder Neoplasms 1Thyroid Neoplasms 1Solid Tumors 1Solid Tumor Malignancies 1

Interventions

Temozolomide 2lutetium Lu 177 dotatate 1copper dotatate CU-64 1Vincristine 1Valproic Acid 1Thiotepa 1Sunitinib 1Radiotherapy 1Peripheral Blood Stem Cell Transplantation 1Melphalan 1Maintenance Chemotherapy 1Lutetium-177 1Lutetium 1Lomustine 1Interleukin-12 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Etoposide 1Erlotinib Hydrochloride 1Cisplatin 1Busulfan 1Bone Marrow Transplantation 1Aminolevulinic Acid 1Amifostine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Neuroectodermal Tumors × Valproic Acid × Clear all
NCT00513162 2012-09-19

Valproate and Etoposide for Patients With Neuronal Tumors and Brain Metastases

M.D. Anderson Cancer Center

Phase 1 Completed
8 enrolled
CNS

Brain Neoplasms, Neuroectodermal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡